Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
EXAS Exact Sciences Corporation daily Stock Chart
EXAS [NASD]
Exact Sciences Corporation
Healthcare | Diagnostics & Research | USA
statements
Index- P/E- EPS (ttm)-1.04 Insider Own0.90% Shs Outstand148.15M Perf Week-2.83%
Market Cap14.24B Forward P/E- EPS next Y-1.11 Insider Trans-14.20% Shs Float147.79M Perf Month6.54%
Income-154.40M PEG- EPS next Q-0.41 Inst Own90.80% Short Float8.97% Perf Quarter18.02%
Sales1.13B P/S12.59 EPS this Y55.40% Inst Trans0.51% Short Ratio9.56 Perf Half Y-4.11%
Book/sh17.13 P/B5.37 EPS next Y47.20% ROA-2.90% Target Price103.36 Perf Year-18.61%
Cash/sh7.95 P/C11.57 EPS next 5Y- ROE-5.30% 52W Range35.25 - 123.31 Perf YTD-0.58%
Dividend- P/FCF- EPS past 5Y12.50% ROI-1.90% 52W High-27.71% Beta1.92
Dividend %- Quick Ratio5.80 Sales past 5Y244.80% Gross Margin75.10% 52W Low152.87% ATR4.01
Employees4110 Current Ratio6.10 Sales Q/Q114.70% Oper. Margin-21.60% RSI (14)40.76 Volatility5.39% 4.34%
OptionableYes Debt/Eq0.61 EPS Q/Q-8.60% Profit Margin-7.40% Rel Volume0.86 Prev Close91.94
ShortableYes LT Debt/Eq0.60 EarningsJul 30 AMC Payout- Avg Volume1.39M Price89.14
Recom1.30 SMA20-6.53% SMA50-1.33% SMA2006.52% Volume604,145 Change-3.05%
Apr-02-20Initiated Evercore ISI Outperform $70
Jan-10-20Resumed BTIG Research Buy $127
Jan-07-20Initiated Citigroup Buy $120
Dec-13-19Initiated Dougherty & Company Buy $120
Nov-15-19Initiated Stifel Buy
Oct-17-19Reiterated BofA/Merrill Buy $130 → $135
Oct-01-19Resumed Craig Hallum Buy $127
Sep-26-19Initiated Oppenheimer Outperform $130
Feb-26-19Upgrade Goldman Neutral → Buy $85 → $120
Oct-09-18Initiated UBS Buy
Sep-05-18Resumed The Benchmark Company Hold
Aug-13-18Reiterated Canaccord Genuity Buy $62 → $65
Apr-03-18Upgrade BTIG Research Neutral → Buy
Jan-29-18Initiated Goldman Neutral $51
Jan-08-18Reiterated The Benchmark Company Buy $60 → $65
Nov-13-17Downgrade Robert W. Baird Outperform → Neutral $56
Nov-01-17Downgrade BTIG Research Buy → Neutral
Oct-31-17Reiterated The Benchmark Company Buy $50 → $60
Oct-03-17Reiterated Canaccord Genuity Buy $45 → $60
Sep-21-17Reiterated Leerink Partners Outperform $45 → $50
Aug-01-20 04:03AM  
Exact Sciences (EXAS) Q2 2020 Earnings Call Transcript
Motley Fool
Jul-31-20 12:13PM  
Exact Sciences' (EXAS) Q2 Earnings Beat, Margin Declines
Zacks
11:13AM  
Why Exact Sciences pivoted into COVID-19 testing
Yahoo Finance Video
06:38AM  
Exact Sciences Beats Q2 Estimates Despite a COVID-19 Drag
Motley Fool
Jul-30-20 06:30PM  
Exact Sciences (EXAS) Reports Q2 Loss, Tops Revenue Estimates
Zacks
Jul-29-20 08:40AM  
Should You Buy Exact Sciences (EXAS) Ahead of Earnings?
Zacks
Jul-23-20 12:32PM  
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Should You Buy?
Zacks
11:30AM  
Has Exact Sciences (EXAS) Outpaced Other Medical Stocks This Year?
Zacks
Jul-17-20 08:00AM  
How Genetic Testing For Cancer Could Create A $51 Billion U.S. Market
Investor's Business Daily
Jul-12-20 12:00PM  
Did Hedge Funds Make The Right Call On XACT Sciences Corporation (EXAS) ?
Insider Monkey
Jul-08-20 07:45AM  
An Intrinsic Calculation For Exact Sciences Corporation (NASDAQ:EXAS) Suggests It's 46% Undervalued
Simply Wall St. +6.21%
06:00AM  
Exact Sciences schedules annual meeting, second quarter 2020 earnings call
PR Newswire
Jun-16-20 03:09PM  
Robinhood traders could learn from this growth-stock investor whos beaten indexes by a wide margin for years
MarketWatch
08:00AM  
Oncotype DX Genomic Prostate Score® Result Shows for the First Time the Value of the Test to Guide Treatment Plans for Unfavorable Intermediate-Risk Prostate Cancer Patients
PR Newswire
Jun-05-20 11:31AM  
Why Is Exact Sciences (EXAS) Up 2.4% Since Last Earnings Report?
Zacks
Jun-03-20 09:49AM  
Edited Transcript of EXAS earnings conference call or presentation 6-May-20 9:00pm GMT
Thomson Reuters StreetEvents
01:15AM  
Hedge Funds Cashing Out Of EXACT Sciences Corporation (EXAS)
Insider Monkey
May-29-20 08:00AM  
Exact Sciences Showcases Continued Progress in Cancer Diagnostics at ASCO 2020
PR Newswire
May-26-20 06:00AM  
Exact Sciences to participate in June investor conferences
PR Newswire
May-17-20 06:46AM  
Could Exact Sciences Be a Millionaire-Maker Stock?
Motley Fool
May-12-20 03:10PM  
Pivoting From Poop: How Exact Sciences is Turning to Option #2
Yahoo Finance Video
10:23AM  
Is Exact Sciences Stock a Buy?
Motley Fool
May-11-20 10:19AM  
Should Investors Buy the Dip in EXACT Sciences (EXAS) Stock?
Insider Monkey
May-07-20 11:30AM  
Exact Sciences Corp (EXAS) Q1 2020 Earnings Call Transcript
Motley Fool +6.35%
10:09AM  
Exact Sciences' (EXAS) Q1 Earnings Fall Y/Y, Margin Expands
Zacks
May-06-20 08:05PM  
Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates
Zacks
03:00PM  
EXACT Sciences Corp. to Host Earnings Call
ACCESSWIRE
May-05-20 10:30AM  
New Model Shared at Digestive Disease Week (DDW) Demonstrates the Value of Cologuard® When Using Real-World Adherence Rates for Comparing Colorectal Cancer Screening Methods
PR Newswire
10:16AM  
Should You Buy Exact Sciences (EXAS) Ahead of Earnings?
Zacks
10:06AM  
Varian (VAR) Earnings and Revenues Surpass Estimates in Q2
Zacks
08:45AM  
Buy 5 Top Stocks Set to Beat Earnings Estimates Tomorrow
Zacks
May-04-20 06:00AM  
Exact Sciences to participate in May investor conference
PR Newswire
May-03-20 07:36AM  
2 Cheap Healthcare Stocks to Buy Now
Motley Fool
Apr-30-20 10:49AM  
Surmodics (SRDX) Q2 Earnings and Revenues Beat Estimates
Zacks
Apr-29-20 12:34PM  
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks
Apr-22-20 05:20AM  
Exact Sciences Reports 63% Reduction For Cologuard Testing in April
SmarterAnalyst
Apr-08-20 05:51PM  
Why 'Kimtirement' is a real thing with this longtime biotech exec
American City Business Journals +6.02%
06:00AM  
Exact Sciences schedules first-quarter 2020 earnings call
PR Newswire
Apr-02-20 09:00AM  
10x Genomics Appoints Kim Popovits to Board of Directors
GlobeNewswire
06:00AM  
Exact Sciences Highlights The Opportunity To Seek Screening With Cologuard® Through Telehealth
PR Newswire
Mar-26-20 05:45PM  
Exact Sciences (EXAS) Stock Sinks As Market Gains: What You Should Know
Zacks
01:50PM  
Epic, Exact Sciences among Wisconsin tech firms responding to COVID-19
American City Business Journals
Mar-24-20 09:44AM  
Exact Sciences Grows on New Deals, Down on Coronavirus Scare
Zacks +16.11%
Mar-21-20 09:22AM  
Is Exact Sciences Corporation's (NASDAQ:EXAS) CEO Pay Fair?
Simply Wall St.
Mar-19-20 06:00AM  
Exact Sciences Takes Action during COVID-19 Pandemic
PR Newswire +32.48%
Mar-17-20 05:45PM  
Exact Sciences (EXAS) Gains But Lags Market: What You Should Know
Zacks
03:18PM  
Hedge Funds Have Never Been This Bullish On EXACT Sciences Corporation (EXAS)
Insider Monkey
Mar-12-20 11:30AM  
Exact Sciences (EXAS) Down 39.7% Since Last Earnings Report: Can It Rebound?
Zacks -10.91%
Mar-04-20 07:37AM  
The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies
Benzinga
Feb-27-20 08:42AM  
Genetic Test Gets Okayed by FDA: 4 Stocks to Keep an Eye On
Zacks
Feb-25-20 08:28AM  
The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement
Benzinga -9.44%
Feb-24-20 10:39PM  
Exact Sciences Announces Upsizing and Pricing of 0.3750% Convertible Senior Notes Due 2028
PR Newswire
04:01PM  
Exact Sciences Announces Offering of $850 Million Convertible Senior Notes Due 2028
PR Newswire
Feb-19-20 05:44AM  
Bull of the Day: Guardant Health (GH)
Zacks
Feb-17-20 05:24AM  
Edited Transcript of EXAS earnings conference call or presentation 11-Feb-20 10:00pm GMT
Thomson Reuters StreetEvents
Feb-12-20 03:52PM  
Exact Sciences to acquire more biotech companies; plans to launch liver cancer test in 2020
American City Business Journals
09:18AM  
The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data
Benzinga
08:56AM  
Exact Sciences (EXAS) Q4 Earnings and Revenues Rise Y/Y
Zacks
Feb-11-20 06:15PM  
Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates
Zacks
05:07PM  
Exact Sciences beats income, revenue projections in 4Q earnings report
American City Business Journals
04:05PM  
Exact Sciences Announces Fourth-Quarter 2019 Results
PR Newswire
07:23AM  
The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology
Benzinga
Feb-04-20 06:41PM  
Should Growth Investors Buy this Cancer Screening Biotech Stock?
Zacks
12:30PM  
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks
11:44AM  
What's in the Cards for Exact Sciences' (EXAS) Q4 Earnings?
Zacks
Feb-03-20 05:45PM  
Exact Sciences (EXAS) Outpaces Stock Market Gains: What You Should Know
Zacks
04:05PM  
Eaton Vance Worldwide Health Sciences Fund Buys 3 Stocks in 4th Quarter
GuruFocus.com
01:01PM  
Exact Sciences doubled capital investment, job creation goal in Wisconsin, per report
American City Business Journals
Jan-27-20 05:50PM  
Exact Sciences (EXAS) Dips More Than Broader Markets: What You Should Know
Zacks
06:00AM  
Exact Sciences schedules fourth-quarter, full-year 2019 earnings call
PR Newswire
Jan-24-20 11:24AM  
Exact Sciences, GameStop, Intel, Intuitive Surgical and Skyworks highlighted as Zacks Bull and Bear of the Day
Zacks
09:55AM  
What's in Store for IDEXX Laboratories' (IDXX) Q4 Earnings?
Zacks
09:06AM  
Can Critical Care Aid Edwards Lifesciences (EW) Q4 Earnings?
Zacks
05:20AM  
Bull of the Day: Exact Sciences (EXAS)
Zacks
Jan-23-20 01:30PM  
Exact Sciences' stock jumps after analysts question competitor's product
American City Business Journals
10:45AM  
Will New Buyouts Aid Quest Diagnostics (DGX) Q4 Earnings?
Zacks
09:17AM  
Will Segmental Growth Aid Hologic (HOLX) in Q1 Earnings?
Zacks
08:23AM  
What's in Store for Align Technology's (ALGN) Q4 Earnings?
Zacks
Jan-22-20 07:30AM  
Exact Sciences Gains After Rival's Colorectal Cancer Screening Product Falls Short
TheStreet.com +10.55%
Jan-21-20 06:31AM  
Is Exact Sciences Corporation (NASDAQ:EXAS) Trading At A 40% Discount?
Simply Wall St.
Jan-20-20 09:13AM  
Can Abbott (ABT) Q4 Earnings Ride on Growth in All Lines?
Zacks
Jan-17-20 09:15AM  
Another Milestone After Another Trade Deal
Zacks
07:10AM  
Exact Sciences (EXAS) Provides Q4 Expectations, Stock Falls
Zacks
Jan-16-20 02:53PM  
6 Guru Stocks With Negative Performances
GuruFocus.com
09:52AM  
Novavax Rises on Fast Track Designation to Influenza Vaccine
Zacks
Jan-15-20 09:36AM  
Perrigo (PRGO) Rises on Stellar Q419 Preliminary Results
Zacks
Jan-14-20 01:44PM  
Exact Sciences (EXAS) Stock Has 40% Upside From Here, Says Analyst
TipRanks
04:41AM  
Can Focus on High-Growth Area Up OrganiGram (OGI) Q1 Earnings?
Zacks
Jan-13-20 01:51PM  
Exact Sciences anticipates 2019 revenue over $876M, more than 1.6M completed Cologuard tests
American City Business Journals -13.67%
11:30AM  
Has Exact Sciences (EXAS) Outpaced Other Medical Stocks This Year?
Zacks
10:17AM  
All 4 of Analysts' Favorite Stocks Fell Last Year
GuruFocus.com
10:16AM  
Can New Strategic Efforts Aid Apharia's (APHA) Q2 Earnings?
Zacks
09:13AM  
Top Ranked Momentum Stocks to Buy for January 13th
Zacks
08:14AM  
Can Cannabis Therapy Drive Aphria's (APHA) Q2 Earnings?
Zacks
Jan-12-20 07:00PM  
Exact Sciences Announces Preliminary Fourth Quarter 2019 Results
PR Newswire
Jan-07-20 10:08AM  
Exact Sciences Rides on Cologuard, Eyes Merger Synergies
Zacks
Jan-06-20 09:55AM  
Walgreens Boots (WBA) to Post Q1 Earnings: What's in Store?
Zacks
Jan-02-20 06:00AM  
Exact Sciences to participate in J.P. Morgan Healthcare Conference
PR Newswire
Dec-31-19 12:00AM  
Bitcoins 9,000,000% Rise This Decade Leaves the Skeptics Aghast
Bloomberg
Dec-26-19 12:05PM  
EXACT Sciences Corporation (EXAS) vs. Top 20 Hedge Fund Stocks in 2019
Insider Monkey
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; and Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer. The company's pipeline products focuses on the research and development of enhancing Cologuard's performance characteristics, and blood or other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; Biocartis N.V.; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Conroy Kevin TPresident and CEOAug 03Sale93.8025,1982,363,560968,266Aug 04 05:18 PM
Carey Thomas D.DirectorJul 31Option Exercise9.2415,620144,32952,492Aug 04 05:21 PM
Zanotti Katherine SDirectorJul 31Option Exercise8.5221,029179,16762,936Aug 04 04:54 PM
LEVANGIE DANIEL JDirectorJul 31Option Exercise9.309,86591,69924,881Aug 04 04:58 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 31Option Exercise21.686,638143,91275,861Aug 04 05:02 PM
Carey Thomas D.DirectorJul 31Sale94.0030,6202,878,28021,872Aug 04 05:21 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 31Sale93.8337,5003,518,77138,361Aug 04 05:02 PM
LEVANGIE DANIEL JDirectorJul 31Sale94.009,865927,31015,016Aug 04 04:58 PM
Zanotti Katherine SDirectorJul 31Sale94.0021,0291,976,72641,907Aug 04 04:54 PM
Doyle James EdwardDirectorJul 31Sale94.002,539238,66632,459Aug 04 04:45 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 29Sale95.588,746835,94369,223Jul 30 08:18 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 28Option Exercise94.8118,7501,777,68877,969Jul 30 08:18 PM
Zanotti Katherine SDirectorJul 28Sale96.131,164111,89541,907Jul 30 06:49 PM
Stenhouse MarkPresident, CologuardApr 03Sale56.6911,948677,33229,571Apr 06 04:41 PM
Stenhouse MarkPresident, CologuardApr 02Option Exercise0.0025,000041,519Apr 06 04:41 PM
Doyle James EdwardDirectorFeb 28Sale77.542,000155,08032,440Mar 03 07:20 PM
Conroy Kevin TPresident and CEOFeb 28Sale80.179,750781,658992,963Mar 02 07:13 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 28Sale80.172,383191,04558,578Mar 02 07:15 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 27Option Exercise0.005,025061,141Mar 02 07:15 PM
Conroy Kevin TPresident and CEOFeb 27Option Exercise0.0020,57501,002,713Mar 02 07:13 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 27Sale80.271,627130,59956,116Feb 28 04:37 PM
Stenhouse MarkPresident, CologuardFeb 27Sale80.271,05184,36416,519Feb 28 04:39 PM
Conroy Kevin TPresident and CEOFeb 27Sale80.2713,8751,113,746982,138Feb 28 04:36 PM
Conroy Kevin TPresident and CEOFeb 26Option Exercise0.0029,3370996,013Feb 28 04:36 PM
Stenhouse MarkPresident, CologuardFeb 26Option Exercise0.003,262017,570Feb 28 04:39 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 26Option Exercise0.003,436057,743Feb 28 04:37 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 25Sale85.114,910417,89054,307Feb 26 05:13 PM
Conroy Kevin TPresident and CEOFeb 25Sale85.1118,1151,541,768966,676Feb 26 05:11 PM
Conroy Kevin TPresident and CEOFeb 24Option Exercise0.0034,3250984,791Feb 26 05:11 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 24Option Exercise0.009,300059,217Feb 26 05:13 PM
Cole G BradleyGeneral Manager - DiagnosticsFeb 19Option Exercise35.7717,356620,77637,550Feb 21 04:58 PM
Cole G BradleyGeneral Manager - DiagnosticsFeb 19Sale100.0027,3562,735,60010,194Feb 21 04:58 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 19Sale100.681,153116,0842,495Feb 20 05:55 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 18Option Exercise0.003,64803,648Feb 20 05:55 PM
Hoof TorstenGeneral Manager, InternationalFeb 15Option Exercise0.002,09105,914Mar 27 04:15 PM
Cole G BradleyGeneral Manager - DiagnosticsJan 16Sale90.3010,000903,0008,653Jan 17 04:50 PM
Conroy Kevin TPresident and CEODec 16Option Exercise17.4811,440199,992950,466Dec 18 05:19 PM
Cole G BradleyGeneral Manager - DiagnosticsNov 21Sale80.3828,0162,251,92630,987Nov 25 05:18 PM
Johnson Scott C.SVP - Research and DevelopmentSep 12Sale108.633,527383,13812,311Sep 13 04:52 PM
Johnson Scott C.SVP - Research and DevelopmentSep 11Option Exercise0.007,500015,838Sep 13 04:52 PM
open in yahoo | open in reuters | open in google